Validation of Hepascore as a Predictor of Liver Fibrosis in Patients with Chronic Hepatitis C Infection

<table class="table-group" id="tab2"><tr><td><table class="table"><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr class="thead"><td align="left"> Severity of fibrosis</td><td align="center">No. of patients</td><td align="center">%</td></tr><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr><td align="left">F0</td><td align="center">12</td><td align="center">15</td></tr><tr><td align="left">F1</td><td align="center">25</td><td align="center">31.25</td></tr><tr><td align="left">F2</td><td align="center">20</td><td align="center">25</td></tr><tr><td align="left">F3</td><td align="center">7</td><td align="center">8.75</td></tr><tr><td align="left">F4</td><td align="center">16</td><td align="center">20</td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Frequency distribution for fibrosis severity according to the biopsy results.

Hepatitis Research and Treatment

tab2

Table 2

Table 2: Validation of Hepascore as a Predictor of Liver Fibrosis in Patients with Chronic Hepatitis C Infection 